1. South Korea Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
GREEN LIFESCIENCE CO. LTD.

GREEN LIFESCIENCE CO. LTD.

KKRX:114450
2,180.00
KRW
+35.00
(+1.63%)
156.16EPS
17.19P/E
53.26BMarket Cap
GREEN LIFESCIENCE CO. LTD.
KRX:114450
(Korea Stock Exchange)

Recent

price

2,180.00

P/E

ratio

17.19

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
1,827.05
2,758.28
2,711.33
1,717.34
1,859.78
2,274.7
2,163.08
2,124.77
1,631.71
1,887.66
1,234.42
1,266.53
1,824.95
1,121.36
1,289.22
2,197.7
2,646.23
Revenue per Share
240.75
161.48
121.5
-65.25
-53.25
269.25
225
111
-72
60
-53.25
-156.75
-176.25
-820
81
6
156.16
Basic EPS, GAAP
-279.79
-569.2
236.2
-177.71
158.36
254.44
272.98
68.47
-105.16
32.18
-38.45
-141.57
-301.44
-5.26
3.26
-43.39
-172.98
Free Cash Flow per Basic Share
169.01
168.75
168.86
373.06
- -
- -
- -
100.29
74.73
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3,036.75
3,108.76
3,043.64
2,605.73
2,576.48
2,844.83
3,083.16
3,104.6
2,955.57
3,017.88
2,968.56
2,814.92
2,631.95
1,812.66
1,872.83
1,930.08
2,018.53
Book Value per Share
3,017.15
3,017.1
2,970.01
2,519.04
2,538.49
2,809.35
3,037.81
3,061.4
2,921.2
2,984.83
2,950.04
2,805.83
2,627.55
1,811.26
1,867.1
1,916.7
1,990.22
Tangible Book Value per Share
20
20
20
20
20
20
20
20
20
20
20
20
20
20
19
18
19
Basic Weighted Avg Shares
36,485
55,166
54,192
34,526
37,081
45,508
43,304
42,585
32,754
37,618
24,561
25,338
36,505
22,369
24,861
40,340
51,017
Sales/Revenue/Turnover
7.81
6.15
5.8
-5.56
-4.94
12.19
11.62
5.65
-5.96
1.57
-7.77
-18.35
-10.84
-20.76
1.52
0.51
3.86
Operating Margin (%)
1,953
2,411
3,323
2,742
2,635
2,990
3,420
3,402
3,510
3,380
2,668
2,565
2,769
2,476
769
790
773
Depreciation Expense
4,808
3,230
2,428
-1,312
-1,062
5,387
4,504
2,225
-1,445
1,196
-1,059
-3,136
-3,526
-16,358
1,562
110
3,011
Net Income, GAAP
13.38
7.59
16.6
- -
- -
16.27
20.77
14.25
- -
10.76
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
13.18
5.85
4.48
-3.8
-2.86
11.84
10.4
5.22
-4.41
3.18
-4.31
-12.38
-9.66
-73.13
6.28
0.27
5.9
Profit Margin (%)
39,475
26,963
28,558
18,066
19,458
16,878
28,504
28,180
20,693
20,590
13,791
11,651
17,007
14,319
13,677
16,667
17,975
Working Capital
- -
- -
- -
7,000
7,000
- -
- -
- -
- -
- -
31
58
18
29
531
368
344
LT Debt
60,735
62,175
60,873
52,115
51,530
56,897
61,663
62,092
59,111
60,358
59,371
56,298
52,639
35,954
35,748
38,288
40,043
Total Equity
3.83
4.82
3.93
- -
- -
7.34
5.94
3.04
- -
0.81
- -
- -
- -
- -
0.92
0.47
4.62
Return on Invested Capital (%)
7.65
5.33
4.24
- -
- -
8.95
6.95
3.36
- -
1.87
- -
- -
- -
- -
4.39
0.82
7.6
Return on Capital (%)
8.01
5.26
3.95
-2.32
-2.05
9.94
7.6
3.6
-2.38
2
-1.77
-5.42
-6.47
-36.93
4.36
0.3
8.07
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
6,750
6,624
4,912
LT Borrowings
- -
- -
- -
LT Finance Leases
453
368
344
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
20
20
Market Capitalization
49,818
57,529
53,264

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
26,958
32,678
33,330
Cash, Cash Equivalents & STI
14,300
17,186
13,573
Accounts Receivable, Net
7,069
6,893
8,903
Inventories
5,367
8,418
10,535
Total Current Liabilities
14,190
16,011
15,355
Payables & Accruals
- -
- -
- -
ST Debt
6,750
6,624
4,912
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.21%
-7.37%
7.11%
Free Cash Flow
-191.45%
-248.68%
-1,368.43%
Net Income, GAAP
-23.34%
73.98%
-92.95%
Sales/Revenue/Turnover
3.25%
16.38%
62.26%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,541
6,914
4,450
6,955
24,861
2025
4,872
11,479
11,350
12,638
40,340
2026
15,549
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
55
70
-58
13.3
81
2025
-60
1.89
25.68
38.19
6
2026
88.46
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
Aether Industries Ltd. (NSE:AETHER)
AARTI Industries Ltd (NSE:AARTIIND)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Green LifeScience Co., Ltd. is a South Korea-based fine chemical and life sciences company that specializes in the research, development, custom synthesis, and manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, agrochemical raw materials, and advanced electronic materials. Founded in 2005 and headquartered in Yeosu, South Korea, the company operates cGMP-compliant synthesis facilities and supplies high-purity chemical compounds to domestic and multinational pharmaceutical, agricultural, and industrial markets. The company's core product and service offerings comprise: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates, including piperacillin-based antibiotic intermediates such as EDP-CL and AM19; N,N'-disuccinimidyl carbonate (DSIC) utilized in the synthesis of antiretroviral HIV treatments; 1,1'-carbonyldiimidazole (CDI) coupling reagents; Amoxapine antidepressant raw materials; and intermediate compounds for cardiovascular, oncological, and antimicrobial formulations; Agrochemical Raw Materials and Intermediates, including AMZ, CCIM, and IKF-309 compounds formulated for crop protection, fungicides, and pesticide manufacturing; Advanced Specialty and Electronic Materials, encompassing high-purity chemical compounds and process materials developed for semiconductor and AI hardware manufacturing applications; and Custom Synthesis and Contract Manufacturing Services, delivering multi-step chemical synthesis, process optimization, phosgenation, hydrogenation, and peptide chemistry solutions. Geographically, the company distributes its products domestically and exports to global markets, including the United States, Japan, and Brazil. In recent corporate developments, the company, formerly known as KPX Life Science Co., Ltd., completed a corporate name change to Green LifeScience Co., Ltd. to align with its expanded strategic scope. Demonstrating strategic diversification beyond life sciences, the company entered the advanced technology supply chain by securing major supply agreements for AI semiconductor materials with Green Chemical Co., Ltd. In addition, Green LifeScience expanded its international agrochemical business through substantial supply contracts for plant health and crop protection chemicals with global agricultural partners such as UPL Limited targeting the Brazilian market, while advancing new capital facility investments and adjustments to its major shareholding structure to support production scalability.